Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. - Yoshida,H.; Ishiko,O.; Sumi,T.; Matsumoto,Y.; Ogita,S. (Int J Oncol, 2001)